반응식
[CH3:1][N:2]1[C:6](=[O:7])[CH2:5][CH2:4][C@H:3]1[C:8]1[CH:13]=[CH:12][CH:11]=[N:10][CH:9]=1.[CH:14]([C:17]1[CH:22]=[CH:21][CH:20]=[C:19]([CH:23]([CH3:25])[CH3:24])[C:18]=1[N:26]=[C:27]=[O:28])([CH3:16])[CH3:15].C([N-]C(C)C)(C)C.[Li+]>>[CH3:16][CH:14]([C:17]1[CH:22]=[CH:21][CH:20]=[C:19]([CH:23]([CH3:24])[CH3:25])[C:18]=1[NH:26][C:27]([CH:5]1[CH2:4][CH:3]([C:8]2[CH:9]=[N:10][CH:11]=[CH:12][CH:13]=2)[N:2]([CH3:1])[C:6]1=[O:7])=[O:28])[CH3:15]참가 물질
4
실험 절차
The title compound was prepared from (-)-cotinine (5.0 g, 0.028 mol), 2,6-diisopropylphenyl isocyanate (5.69 g, 0.028 mol) and lithium diisopropylamide (0.028 mol) using the procedure described in Example 1.
출처 및 근거
- ORD 기록
- ord-ae4675954e294dd08b3f057fe3613566
- 출처 데이터셋
- uspto-grants-1993_02
- 특허 번호
- US05185349
연결된 노트
불러오는 중…